Ventured Growth with Hercules Capital

Jul 18 2024 34 ep. 37 mins 7
Ventured Growth with Hercules Capital Podcast artwork

Join Hercules Capital in conversations with today’s top CEOs, CFOs, and investors in venture and private equity-backed companies. Learn about their strategies for financing rapid growth and scaling their businesses, as well as their unique interests and life stories that have shaped their paths to success.

  Business
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


#33 - How Corporate Venture Capital is Driving Healthcare Innovation | Vijay Patel

Jul 18 2024 57 mins  
Vijay Patel is an institutional investor turned corporate venture capitalist. He has spent the last decade at the intersection of finance and healthcare, changing the way CVS Health approaches innovation and strategic investments. His journey from traditional venture capital to leading CVS Health® Ventures has positioned him as a thought leader in corporate venture capital and hea

#32 - The Future of Drug Affordability and Access | Peter Kolchinsky

Jun 27 2024 56 mins  
In an era where breakthrough innovations coexist with concerns over drug affordability, Peter Kolchinsky, founder and Managing Partner at healthcare and life sciences investment manager RA Capital, joins us to shed light on the factors and paths forward.Hercules Capital's Janice Bourque engages with Peter on his No Patient Left Behind initiative, a non-profit dedicated to making me

#31 - Dynamics of Venture Debt: Balancing Legal and Business Objectives | David Ephraim

May 09 2024 26 mins  
Navigating the intricate world of venture debt requires a deep understanding of both the legal landscape and financial imperatives. David Ephraim from Morrison & Foerster brings over two decades of experience to the table, making him a leading authority on structuring deals that align legal precision with business innovation.This episode, hosted by Janice Bourque from Hercules

#30 – Rise of the Business Operator: Cultivating the Ultimate Community of Tech Leaders | Casey Woo

Mar 14 2024 50 mins  
Public market investor turned tech visionary, Casey Woo, has spent the last two decades at the forefront of technology and finance, revolutionizing the way high-growth startups approach operations and strategy. His journey from analyzing markets on Wall Street to leading Operators Guild and FOG Ventures has positioned him as a thought leader at the intersection of technology, finan

#29 – Endpoints News: Predictions for Biotech in 2024 and Beyond | John Carroll

Jan 25 2024 46 mins  
In the aftermath of the 2020 biotech surge and its subsequent contraction in 2022, the biotech industry has been characterized by significant volatility. There were 21 biotechnology IPOs in 2022, a notable decrease from the record-breaking 104 IPOs in 2021.To review the highs and lows of 2023 and explore what lies ahead in 2024, distinguished biotech analyst and co-founder of Endpo

#28 – The Non-CFO, CFO: Executive Leadership, Acquisitions, and Serving 350 Million Users as Fandom’s CFO | Ed Lu

Jan 04 2024 56 mins  
The gaming and platform industries are dynamic sectors at the intersection of technology and entertainment, constantly evolving to meet the demands of a global audience. In 2022, the revenue from the worldwide gaming market was approximately $347 billion. Ed Lu, a seasoned executive with 23 years of financial and operational experience, has played a pivotal role in this landscape,

#27 – The Evolution of Biotech: Lessons From 35 Years of Early Stage Investing | Terry McGuire

Dec 14 2023 34 mins  
Healthcare and biotech venture capital plays a critical role in funding innovative medical technologies, drug development, and life-saving therapies. These investments drive advancements in healthcare, transforming science into products that improve global patient outcomes.Terry McGuire is a founding partner of Polaris Partners, with over 35 years of early-stage investing experienc

#26 – Biotech and the Public: Breakthroughs, Drug Prices, and Public Relations | Rich Aldrich

Nov 30 2023 40 mins  
In the dynamic field of life sciences, skillful operators ensure the efficient development of medical innovations, while insightful investors provide crucial capital and strategic guidance. Rich Aldrich's 30+ year career uniquely bridges both sides, having played key roles in founding and managing successful ventures in the industry.Rich Aldrich is a co-founder and partner at Longw

#25 – From Physician to Founder: Scaling Iora Health to a $2 Billion Exit | Rushika Fernandopulle

Nov 09 2023 33 mins  
The healthcare space has long been a transactional one, seeing patients as numbers instead of human relationships. In 2004, Dr. Rushika Fernandopulle began to challenge the status quo and create an entirely new model of care delivery that finally put patients at the center of healthcare. Rushika Fernandopulle is the co-founder and former CEO of Iora Health, a value-based primary ca

#24 – Scaling up in Biotech, Raising $300M for a Single Pharma Product | Mark Hahn

Oct 12 2023 31 mins  
Successful biotech companies require a capable CFO to guide the company through conducting clinical trials, securing regulatory approvals, establishing scalable production, and adeptly conveying value to healthcare stakeholders.Mark Hahn is a seasoned executive with over 25 years of CFO experience. He is currently the CFO of Verona Pharma, a clinical-stage biopharmaceutical company